Login / Signup

Temporarily Reversing Warfarin With Low-Dose 4-Factor Prothrombin Complex Concentrate in Left Ventricular Assist Device Patients Undergoing an Invasive Procedure.

Byron StevensonA Joshua RobertsWilliam E Dager
Published in: The Annals of pharmacotherapy (2024)
Low-dose PCC4 appears to be a safe and effective temporary reversal strategy for patients with LVADs undergoing low-bleed risk elective procedures.
Keyphrases
  • low dose
  • left ventricular assist device
  • patients undergoing
  • high dose
  • atrial fibrillation
  • venous thromboembolism
  • minimally invasive
  • direct oral anticoagulants